Fissiha Workye, Kinde Mebrie Zemene
Department of Epidemiology and Public Health, College of Veterinary Medicine and Animal Sciences, University of Gondar, Gondar, Amhara Regional State, Ethiopia.
Department of Veterinary Biomedical Sciences, College of Veterinary Medicine and Animal Sciences, University of Gondar, Gondar, Amhara Regional State, Ethiopia.
Infect Drug Resist. 2021 Dec 15;14:5403-5410. doi: 10.2147/IDR.S332378. eCollection 2021.
Helminths are a various types of parasites causing a major health problem for animals in different parts of the globe. Control of helminthiasis has largely relied on the use of pharmaceutical anthelmintics. Unfortunately, the exhaustive use of anthelmintic drugs has led to a serious and dramatic level of anthelmintic resistance. Anthelmintic resistance is a heritable loss of sensitivity of an anthelmintic in a parasite population that was in the past susceptible to the same anthelmintic. The development of anthelmintic resistance is evident to different helminths of almost every animal species and to different groups of anthelmintic in several continents. Frequent treatment, underdosing, genetics of the parasite, and targeting and timing of mass treatment are predisposing factors for anthelmintic resistance. Upregulation of cellular efflux mechanisms, an increase in drug metabolism, a change in drug receptor sites that reduces drug binding or the functional consequences of drug binding, and a decrease in drug receptor abundance through reduced expression within the parasite are the main mechanisms of anthelmintic resistance. In vivo method like fecal egg count reduction test and in vitro method such as egg hatch assays, larval motility test, larval development test and PCR can be used for the detection of anthelmintic resistance. Proper utilization of anthelmintic drugs, using combined anthelmintic and applying other alternatives are essential strategies to slow down the development of anthelmintic resistance. As anthelmintic resistance is a serious challenge throughout the world, proper utilization of the existing anthelmintics and reducing dependence on anthelmintics should be implemented to reduce its challenge.
蠕虫是导致全球不同地区动物出现重大健康问题的各类寄生虫。蠕虫病的防治很大程度上依赖于使用抗蠕虫药物。不幸的是,抗蠕虫药物的过度使用已导致严重且显著的抗蠕虫药耐药性。抗蠕虫药耐药性是寄生虫种群中对某种抗蠕虫药的敏感性出现遗传性丧失,而该种群过去对同一抗蠕虫药是敏感的。抗蠕虫药耐药性的发展在几乎每个动物物种的不同蠕虫以及几大洲的不同抗蠕虫药类别中都很明显。频繁治疗、剂量不足、寄生虫的遗传学因素以及群体治疗的靶向性和时机是抗蠕虫药耐药性的诱发因素。细胞外排机制上调、药物代谢增加、药物受体位点改变导致药物结合减少或药物结合的功能后果改变,以及通过寄生虫内表达降低导致药物受体丰度下降,是抗蠕虫药耐药性的主要机制。粪便虫卵计数减少试验等体内方法以及虫卵孵化试验、幼虫活力试验、幼虫发育试验和聚合酶链反应等体外方法可用于检测抗蠕虫药耐药性。合理使用抗蠕虫药物、联合使用抗蠕虫药以及采用其他替代方法是减缓抗蠕虫药耐药性发展的关键策略。由于抗蠕虫药耐药性在全球都是一项严峻挑战,应实施合理使用现有抗蠕虫药并减少对抗蠕虫药的依赖,以应对这一挑战。